References
- A LawAtlas Project. (2019). Syringe distribution laws. http://www.lawatlas.org/datasets/syringe-policies-laws-regulating-non-retail-distribution-of-drug-parapherna
- Akaike, H. (1974). A new look at the statistical model identification. IEEE Transactions on Automatic Control, 19(6), 716–723. https://doi.org/https://doi.org/10.1109/TAC.1974.1100705
- Allen, S. T., Grieb, S. M., O’Rourke, A., Yoder, R., Planchet, E., White, R. H., & Sherman, S. G. (2019). Understanding the public health consequences of suspending a rural syringe services program: A qualitative study of the experiences of people who inject drugs. Harm Reduction Journal, 16(1), 33–33. https://doi.org/https://doi.org/10.1186/s12954-019-0305-7
- Anderson, R., Clancy, L., Flynn, N., Kral, A. H., & Bluthenthal, R. (2003). Delivering syringe exchange services through "satellite exchangers": The Sacramento Area Needle Exchange, U.S.A. International Journal on Drug Policy., 14(5-6), 461–466. https://doi.org/https://doi.org/10.1016/S0955-3959(03)00146-4
- Atkins, A., McClung, R. P., Kilkenny, M., Bernstein, K., Willenburg, K., Edwards, A., Lyss, S., Thomasson, E., Panneer, N., Kirk, N., Watson, M., Adkins, E., DiNenno, E., Hogan, V., Neblett Fanfair, R., Napier, K., Ridpath, A. D., Perdue, M., Chen, M., … Oster, A. M. (2020). Notes from the field: Outbreak of human immunodeficiency virus infection among persons who inject drugs—Cabell County, West Virginia, 2018-2019. MMWR. Morbidity and Mortality Weekly Report, 69(16), 499–500. https://doi.org/https://doi.org/10.15585/mmwr.mm6916a2
- Bates, M. C., Annie, F., Jha, A., & Kerns, F. (2019). Increasing incidence of IV-drug use associated endocarditis in southern West Virginia and potential economic impact. Clinical Cardiology, 42(4), 432–437. https://doi.org/https://doi.org/10.1002/clc.23162
- Behrends, C. N., Li, C.-S., & Gibson, D. R. (2017). Decreased odds of injection risk behavior associated with direct versus indirect use of syringe exchange: Evidence from two California cities. Substance Use & Misuse, 52(9), 1151–1159. https://doi.org/https://doi.org/10.1080/10826084.2017.1299182
- Blumenthal, W. J., Springer, K. W., Jones, T. S., & Sterk, C. E. (2002). Pharmacy student knowledge, attitudes, and beliefs about selling syringes to injection drug users. Journal of the American Pharmaceutical Association, 42(6), S34–SS39. https://doi.org/https://doi.org/10.1331/1086-5802.42.0.S34.Blumenthal
- Brady, J. E., Friedman, S. R., Cooper, H. L. F., Flom, P. L., Tempalski, B., & Gostnell, K. (2008). Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002. Journal of Urban Health, 85(3), 323–351. https://doi.org/https://doi.org/10.1007/s11524-007-9248-5
- Canary, L., Hariri, S., Campbell, C., Young, R., Whitcomb, J., Kaufman, H., & Vellozzi, C. (2017). Geographic disparities in access to syringe services programs among young persons with Hepatitis C virus infection in the United States. Clinical Infectious Diseases, 65(3), 514–517. https://doi.org/https://doi.org/10.1093/cid/cix333
- Centers for Disease Control and Prevention. (2019). Viral hepatitis surveillance: United States, 2017. https://www.cdc.gov/hepatitis/statistics/2017surveillance/pdfs/2017HepSurveillanceRpt.pdf
- Chiarello, E. (2016). Nonprescription syringe sales: Resistant pharmacists’ attitudes and practices. Drug and Alcohol Dependence, 166, 45–50. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2016.06.023
- Collier, M. G., Doshani, M., & Asher, A. (2018). Using population based hospitalization data to monitor increases in conditions causing morbidity among persons who inject drugs. Journal of Community Health, 43(3), 598–603. https://doi.org/https://doi.org/10.1007/s10900-017-0458-9
- Compton, W. M., Horton, J. C., Cottler, L. B., Booth, R., Leukefeld, C. G., Singer, M., Cunningham-Williams, R., Reich, W., Fortuin Corsi, K., Staton, M., Fink, J. L., Stopka, T. J., & Spitznagel, E. L. (2004). A multistate trial of pharmacy syringe purchase. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 81(4), 661–670. https://doi.org/https://doi.org/10.1093/jurban/jth149
- Conrad, C., Bradley, H. M., Broz, D., Buddha, S., Chapman, E. L., Galang, R. R., Hillman, D., Hon, J., Hoover, K. W., Patel, M. R., Perez, A., Peters, P. J., Pontones, P., Roseberry, J. C., Sandoval, M., Shields, J., Walthall, J., Waterhouse, D., Weidle, P. J., Wu, H., & Duwve, J. M. (2015). Community outbreak of HIV infection linked to injection drug use of oxymorphone–Indiana. MMWR. Morbidity and Mortality Weekly Report, 64(16), 443–444.
- Cooper, E. N., Dodson, C., Stopka, T. J., Riley, E. D., Garfein, R. S., & Bluthenthal, R. N. (2010). Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco counties, 2007. Journal of Urban Health, 87(4), 543–552. https://doi.org/https://doi.org/10.1007/s11524-010-9483-z
- Cooper, H. L., Bossak, B., Tempalski, B., Des Jarlais, D. C., & Friedman, S. R. (2009). Geographic approaches to quantifying the risk environment: Drug-related law enforcement and access to syringe exchange programmes. The International Journal on Drug Policy, 20(3), 217–226. https://doi.org/https://doi.org/10.1016/j.drugpo.2008.08.008
- Cotten-Oldenburg, N. U., Carr, P., DeBoer, J. M., Collison, E. K., & Novotny, G. (2001). Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999. Journal of Acquired Immune Deficiency Syndromes, 27(2), 183–192. https://doi.org/https://doi.org/10.1097/00126334-200106010-00014
- Cranston, K., Alpren, C., John, B., Dawson, E., Roosevelt, K., Burrage, A., Bryant, J., Switzer, W. M., Breen, C., Peters, P. J., Stiles, T., Murray, A., Fukuda, H. D., Adih, W., Goldman, L., Panneer, N., Callis, B., Campbell, E. M., Randall, L., … DeMaria, A. (2019). Notes from the field: HIV diagnoses among persons who inject drugs—Northeastern Massachusetts, 2015-2018. MMWR. Morbidity and Mortality Weekly Report, 68(10), 253–254. https://doi.org/https://doi.org/10.15585/mmwr.mm6810a6
- Crowley, J. S., & Millett, G. A. (2017). Preventing HIV and hepatitis infections among people who inject drugs: Leveraging an Indiana outbreak response to break the impasse. AIDS and Behavior, 21(4), 968–972. https://doi.org/https://doi.org/10.1007/s10461-017-1731-8
- Daniulaityte, R., Silverstein, S. M., Crawford, T. N., Martins, S. S., Zule, W., Zaragoza, A. J., & Carlson, R. G. (2020). Methamphetamine use and its correlates among individuals with opioid use disorder in a midwestern U.S. city. Substance Use & Misuse, 55(11), 1781–1789. https://doi.org/https://doi.org/10.1080/10826084.2020.1765805
- Deibert, R. J., Goldbaum, G., Parker, T. R., Hagan, H., Marks, R., Hanrahan, M., & Thiede, H. (2006). Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: Structural and individual-level changes, 1996 versus 2003. American Journal of Public Health, 96(8), 1347–1353. https://doi.org/https://doi.org/10.2105/AJPH.2003.032698
- Des Jarlais, D. C., Kerr, T., Carrieri, P., Feelemyer, J., & Arasteh, K. (2016). HIV infection among persons who inject drugs: Ending old epidemics and addressing new outbreaks. AIDS, 30(6), 815–826. https://doi.org/https://doi.org/10.1097/QAD.0000000000001039
- Des Jarlais, D. C., Nugent, A., Solberg, A., Feelemyer, J., Mermin, J., & Holtzman, D. (2015). Syringe service programs for persons who inject drugs in urban, suburban, and rural areas—United States, 2013. MMWR. Morbidity and Mortality Weekly Report, 64(48), 1337–1341. https://doi.org/https://doi.org/10.15585/mmwr.mm6448a3
- Doran, J., Harris, M., Hope, V. D., Wright, T., Edmundson, C., Sinka, K., & Heinsbroek, E. (2020). Factors associated with skin and soft tissue infections among people who inject drugs in the United Kingdom: A comparative examination of data from two surveys. Drug and Alcohol Dependence, 213, 108080. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2020.108080
- Ellis, M. S., Kasper, Z. A., & Cicero, T. J. (2018). Twin epidemics: The surging rise of methamphetamine use in chronic opioid users. Drug Alcohol Dependence, 193, 14–20. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2018.08.029
- Evans, M. E., Labuda, S. M., Hogan, V., Agnew-Brune, C., Armstrong, J., Periasamy Karuppiah, A. B., Blankinship, D., Buchacz, K., Burton, K., Cibrik, S., Hoffman, W., Kirk, N., Lee, C., McGraw, D., Bañez Ocfemia, M. C., Panneer, N., Reynolds, P., Rose, B., Salmon, M., … Mark-Carew, M. (2018). Notes from the field: HIV infection investigation in a rural area—West Virginia, 2017. MMWR. Morbidity and Mortality Weekly Report, 67(8), 257–258. https://doi.org/https://doi.org/10.15585/mmwr.mm6708a6
- Finkelstein, R., Tiger, R., Greenwald, R., & Mukherjee, R. (2002). Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001–2002). Journal of the American Pharmaceutical Association, 42(6), S83–S87. https://doi.org/https://doi.org/10.1331/1086-5802.42.0.S83.Finkelstein
- Fleischauer, A. T., Ruhl, L., Rhea, S., & Barnes, E. (2017). Hospitalizations for endocarditis and associated health care costs among persons with diagnosed drug dependence - North Carolina, 2010-2015. MMWR. Morbidity and Mortality Weekly Report, 66(22), 569–573. https://doi.org/https://doi.org/10.15585/mmwr.mm6622a1
- Fuller, C. M., Galea, S., Blaney, S., Ompad, D. C., Deren, S., Des Jarlais, D., & Vlahov, D. (2004). Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. Ethnicity & Disease, 14, 589–596.
- Garfein, R. S., Stopka, T. J., Pavlinac, P. B., Ross, A., Haye, B. K., Riley, E. D., & Bluthenthal, R. N. (2010). Three years after legalization of nonprescription pharmacy syringe sales in California: Where are we now?Journal of Urban Health, 87(4), 576–585. https://doi.org/https://doi.org/10.1007/s11524-010-9463-3
- Gleghorn, A. A., Jones, T. S., Doherty, M. C., Celentano, D. D., & Vlahov, D. (1995). Acquisition and use of needles and syringes by injection drug users in Baltimore, Maryland. Journal of Acquired Immune Deficiency Syndromes, 10, 97–103.
- Groseclose, S. L., Weinstein, B., Jones, T. S., Valleroy, L. A., Fehrs, L. J., & Kassler, W. J. (1995). Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers–Connecticut, 1992–1993. Journal of Acquired Immune Deficiency Syndromes, 10(1), 82–89
- Hagan, H., Des Jarlais, D. C., Purchase, D., Friedman, S. R., Reid, T., & Bell, T. A. (1993). An interview study of participants in the Tacoma, Washington, syringe exchange. Addiction (Abingdon, England), 88(12), 1691–1697. https://doi.org/https://doi.org/10.1111/j.1360-0443.1993.tb02044.x
- Harris, A. M., Iqbal, K., Schillie, S., Britton, J., Kainer, M. A., Tressler, S., & Vellozzi, C. (2016). Increases in acute hepatitis B virus infections—Kentucky, Tennessee, and West Virginia, 2006-2013. MMWR. Morbidity and Mortality Weekly Report, 65(3), 47–50. https://doi.org/https://doi.org/10.15585/mmwr.mm6503a2
- Hayashi, K., Wood, E., Wiebe, L., Qi, J., & Kerr, T. (2010). An external evaluation of a peer-run outreach-based syringe exchange in Vancouver, Canada. The International Journal on Drug Policy, 21(5), 418–421. https://doi.org/https://doi.org/10.1016/j.drugpo.2010.03.002
- Heckathorn, D. (1997). Respondent driven sampling: A new approach to the study of hidden populations. Social Problems, 44(2), 174–199. https://doi.org/https://doi.org/10.2307/3096941
- Heimer, R., Clair, S., Teng, W., Grau, L. E., Khoshnood, K., & Singer, M. (2002). Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990-2001. Journal of Urban Health, 79(4), 556–570. https://doi.org/https://doi.org/10.1093/jurban/79.4.556
- Institute of Medicine. (2007). Preventing HIV infection among injecting drug users in high-risk countries: An assessment of the evidence. The National Academies Press.
- Irwin, K., Karchevsky, E., Heimer, R., & Badrieva, L. (2006). Secondary syringe exchange as a model for HIV prevention programs in the Russian Federation. Substance Use & Misuse, 41(6-7), 979–999. https://doi.org/https://doi.org/10.1080/10826080600667219
- Iversen, J., Topp, L., Wand, H., & Maher, L. (2012). Individual-level syringe coverage among needle and syringe program attendees in Australia. Drug and Alcohol Dependence., 122(3), 195–200. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2011.09.030
- Janulis, P., Montgomery, B. W., & Anthony, J. C. (2020). Estimated effect of US state syringe sale policy on source of last-used injection equipment. The International Journal on Drug Policy, 76, 102625. https://doi.org/https://doi.org/10.1016/j.drugpo.2019.102625
- Jenness, S. M., Hagan, H., Liu, K.-L., Wendel, T., & Murrill, C. S. (2011). Continuing HIV risk in New York City injection drug users: the association of syringe source and syringe sharing. Subst Use Misuse, 46(2-3), 192–200. https://doi.org/10.3109.10826084.2011.521467https://doi.org/https://doi.org/10.3109/10826084.2011.521467
- Kerr, T., Small, W., Buchner, C., Zhang, R., Li, K., Montaner, J., & Wood, E. (2010). Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. American Journal of Public Health, 100(8), 1449–1453. https://doi.org/https://doi.org/10.2105/AJPH.2009.178467
- Koester, S. K., Bush, T. W., & Lewis, B. A. (2002). Limited access to syringes for injection drug users in pharmacies in Denver, Colorado. Journal of the American Pharmaceutical Association (1996)), 42(6), S88–S91. https://doi.org/https://doi.org/10.1331/1086-5802.42.0.S88.Koester
- Ksobiech, K. (2003). A meta-analysis of needle sharing, lending, and borrowing behaviors of needle exchange program attenders. AIDS Education and Prevention, 15(3), 257–268. https://doi.org/https://doi.org/10.1521/aeap.15.4.257.23828
- Lewis, B. A., Koester, S. K., & Bush, T. W. (2002). Pharmacists’ attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. J Am Pharm Assoc (Wash), 42(6, Supplement 2), S46–S51. https://doi.org/https://doi.org/10.1331/1086-5802.42.0.S46.Lewis
- Lo, Y., Mendell, N., & Rubin, D. (2001). Testing the number of components in a normal mixture. Biometrika, 88(3), 767–778. https://doi.org/https://doi.org/10.1093/biomet/88.3.767
- Lutnick, A., Case, P., & Kral, A. H. (2012). Injection drug users’ perspectives on placing HIV prevention and other clinical services in pharmacy settings. Journal of Urban Health, 89(2), 354–364. https://doi.org/https://doi.org/10.1007/s11524-011-9651-9
- Lutnick, A., Cooper, E., Dodson, C., Bluthenthal, R., & Kral, A. H. (2013). Pharmacy syringe purchase test of nonprescription syringe sales in San Francisco and Los Angeles in 2010. Journal of Urban Health, 90(2), 276–283. https://doi.org/https://doi.org/10.1007/s11524-012-9713-7
- Marks, R. W., Hanrahan, M., Williams, D. H., Goldbaum, G., Thiede, H., & Wood, R. W. (2002). Encouraging pharmacy sale and safe disposal of syringes in Seattle, Washington. Journal of the American Pharmaceutical Association, 42(6), S26–S27. https://doi.org/https://doi.org/10.1331/1086-5802.42.0.S26.Marks
- Meyerson, B. E., Davis, A., Agley, J. D., Shannon, D. J., Lawrence, C. A., Ryder, P. T., Ritchie, K., & Gassman, R. (2018). Predicting pharmacy syringe sales to people who inject drugs: Policy, practice and perceptions. The International Journal on Drug Policy, 56, 46–53. https://doi.org/https://doi.org/10.1016/j.drugpo.2018.02.024
- Meyerson, B. E., Lawrence, C. A., Cope, S. D., Levin, S., Thomas, C., Eldridge, L. A., Coles, H. B., Vadiei, N., & Kennedy, A. (2019). I could take the judgment if you could just provide the service: Non-prescription syringe purchase experience at Arizona pharmacies, 2018. Harm Reduction Journal, 16(1), 57. https://doi.org/https://doi.org/10.1186/s12954-019-0327-1
- Murphy, S., Kelley, M. S., & Lune, H. (2004). The health benefits of secondary syringe exchange. Journal of Drug Issues, 34(2), 245–268. https://doi.org/https://doi.org/10.1177/002204260403400201
- NASEN. (2020). Fresno Needle Exchange Program. https://nasen.org/sep/fresno-needle-exchange-program
- Neaigus, A., Zhao, M., Gyarmathy, V. A., Cisek, L., Friedman, S. R., & Baxter, R. C. (2008). Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal. Journal of Urban Health, 85(3), 309–322. https://doi.org/https://doi.org/10.1007/s11524-008-9271-1
- Noroozi, M., Armoon, B., Ghisvand, H., Noroozi, A., Karimy, M., Bazrafshan, M. R., Marshall, B. D. L., & Dieji, B. (2019). Prevalence and risk factors for injection site skin infections among people who inject drugs (PWID) in Tehran. Journal of Cosmetic Dermatology, 18(1), 258–262. https://doi.org/https://doi.org/10.1111/jocd.12675
- Owczarzak, J., Weicker, N., Urquhart, G., Morris, M., Park, J. N., & Sherman, S. G. (2020). "We know the streets:" Race, place, and the politics of harm reduction. Health & Place, 64, 102376. https://doi.org/https://doi.org/10.1016/j.healthplace.2020.102376
- Paquette, C. E., & Pollini, R. A. (2018). Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review. Drug Alcohol Depend, 188, 239–250. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2018.03.049
- Paquette, C. E., Syvertsen, J. L., & Pollini, R. A. (2018). Stigma at every turn: Health services experiences among people who inject drugs. The International Journal on Drug Policy, 57, 104–110. https://doi.org/https://doi.org/10.1016/j.drugpo.2018.04.004
- Pollini, R. A. (2017). Self-reported participation in voluntary nonprescription syringe sales in California’s Central Valley. Journal of the American Pharmacists Association, 57(6), 677–685. https://doi.org/https://doi.org/10.1016/j.japh.2017.06.017
- Pollini, R. A., Paquette, C. E., Slocum, S., & LeMire, D. (2021). ‘It’s just basically a box full of disease’—Navigating sterile syringe scarcity in a rural New England state. Addiction, 116(1), 107–115. https://doi.org/https://doi.org/10.1111/add.15113
- Pollini, R. A., Rudolph, A. E., & Case, P. (2015). Nonprescription syringe sales: A missed opportunity for HIV prevention in California. Journal of the American Pharmacists Association, 55(1), 31–40. https://doi.org/https://doi.org/10.1331/JAPhA.2015.14148
- Pouget, E. R., Deren, S., Fuller, C. M., Blaney, S., McMahon, J. M., Kang, S. Y., Tortu, S., Andia, J. F., Des Jarlais, D. C., & Vlahov, D. (2005). Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. Journal of Acquired Immune Deficiency Syndromes (1999), 39(4), 471–477. https://doi.org/https://doi.org/10.1097/01.qai.0000152395.82885.c0
- Quinn, B., Chu, D., Wenger, L., Bluthenthal, R. N., & Kral, A. H. (2014). Syringe disposal among people who inject drugs in Los Angeles: The role of sterile syringe source. The International Journal on Drug Policy, 25(5), 905–910. https://doi.org/https://doi.org/10.1016/j.drugpo.2014.05.008
- Rezaei, O., Ghiasvand, H., Higgs, P., Noroozi, A., Noroozi, M., Rezaei, F., Armoon, B., & Bayani, A. (2020). Factors associated with injecting-related risk behaviors among people who inject drugs: A systematic review and meta-analysis study. Journal of Addictive Diseases, 38(4), 420–437. https://doi.org/https://doi.org/10.1080/10550887.2020.1781346
- Snead, J., Downing, M., Lorvick, J., Garcia, B., Thawley, R., Kegeles, S., & Edlin, B. R. (2003). Secondary syringe exchange among injection drug users. Journal of Urban Health, 80(2), 330–348. https://doi.org/https://doi.org/10.1093/jurban/jtg035
- Stopka, T. J., Garfein, R., Riley, E., Rose, V., Kral, A., Ross, A., & Bluthenthal, R. N. (2010). SB 1159 report: An evaluation of over-the-counter sale of sterile syringes in California. Office of AIDS, California Department of Public Health.
- Stopka, T. J., Garfein, R. S., Ross, A., & Truax, S. R. (2007). Increasing syringe access and HIV prevention in California: Findings from a survey of local health jurisdiction key personnel. Journal of Urban Health, 84(1), 116–125. https://doi.org/https://doi.org/10.1007/s11524-006-9122-x
- Strickland, J. C., Havens, J. R., & Stoops, W. W. (2019). A nationally representative analysis of "twin epidemics": Rising rates of methamphetamine use among persons who use opioids. Drug and Alcohol Dependence, 204, 107592https://doi.org/https://doi.org/10.1016/j.drugalcdep.2019.107592
- Syvertsen, J. L., Paquette, C. E., & Pollini, R. A. (2017). Down in the valley: Trajectories of injection initiation among young injectors in California’s Central Valley. The International Journal on Drug Policy, 44, 41–49. https://doi.org/https://doi.org/10.1016/j.drugpo.2017.03.003
- Syvertsen, J. L., & Pollini, R. A. (2020). Syringe access and health harms: Characterizing "landscapes of antagonism" in California’s Central Valley. The International Journal on Drug Policy, 75, 102594. https://doi.org/https://doi.org/10.1016/j.drugpo.2019.10.018
- Taussig, J., Junge, B., Burris, S., Stephen Jones, T., & Sterk, C. E. (2002). Individual and structural influences shaping pharmacists’ decisions to sell syringes to injection drug users in Atlanta, Georgia. Journal of the American Pharmaceutical Association, 42(6), S40–S45. https://doi.org/https://doi.org/10.1331/1086-5802.42.0.S40.Taussig
- Trubatch, B. N., Fisher, D. G., Cagle, H. H., Fenaughty, A. M., & Johnson, M. E. (2000). Nonprescription pharmacy sales of needles and syringes. American Journal of Public Health, 90(10), 1639–1640. https://doi.org/https://doi.org/10.2105/ajph.90.10.1639
- US Surgeon General. (2020). Needle exchange programs: Benefits and challenges/Interviewer. CATO Institute.
- valente, T. W., Foreman, R. K., Junge, B., & Vlahov, D. (2001). Needle-exchange participation, effectiveness, and policy: Syringe relay, gender, and the paradox of public health. Journal of Urban Health, 78(2), 340–349. https://doi.org/https://doi.org/10.1093/jurban/78.2.340
- Vuong, Q. (1989). Likelihood ratio tests for model selection and non-tested hypotheses. Econometrica, 57(2), 307–333. https://doi.org/https://doi.org/10.2307/1912557
- Williams, C. T., & Metzger, D. S. (2010). Race and distance effects on regular syringe exchange program use and injection risks: A geobehavioral analysis. American Journal of Public Health, 100(6), 1068–1074. https://doi.org/https://doi.org/10.2105/AJPH.2008.158337
- Wodak, A., & Cooney, A. (2006). Do needle syringe programs reduce HIV infection among injecting drug users: A comprehensive review of the international evidence. Substance Use & Misuse, 41(6-7), 777–813. https://doi.org/https://doi.org/10.1080/10826080600669579
- Wurcel, A. G., Anderson, J. E., Chui, K. K. H., Skinner, S., Knox, T. A., Snydman, D. R., & Stopka, T. J. (2016). Increasing infectious endocarditis admissions among young people who inject drugs. Open Forum Infectious Diseases, 3(3), 1–5. https://doi.org/https://doi.org/10.1093/ofid/ofw157
- Zlotorzynska, M., Weidle, P. J., Paz-Bailey, G., & Broz, D. (2018). Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities. International Journal on Drug Policy, 62, 51–58. https://doi.org/https://doi.org/10.1016/j.drugpo.2018.08.019